Home

The Erlangen Vesicle Initiative (EVI) brings together clinician and medical-scientists, basic researchers, and technical experts from FAU’s Medical and Natural Sciences Faculties, the MPZPM, MPI, and Siemens Healthineers. Since May 2023, EVI has driven patient-focused EV research by fostering interdisciplinary collaboration, sharing core platforms for EV isolation, characterization and functional analyses, adhering to MISEV standards. Our work spans mechanistic studies, diagnostic biomarker development, and therapeutic applications of EVs in infectious, inflammatory, degenerative, and neoplastic diseases. Through the EVI umbrella we train emerging scientists in translational EV research—advancing discoveries from messenger to medicine.

If you are interested to join, please do not hesitate to contact Prof. Dr. Claudia Günther from the Department of Medicine 1 or PD Dr. Philipp Arnold from the Institute of Functional and Clinical Anatomy.

 

 

_________________________________________________________________________________________________________________________________________________________

Top News

Dear EV friends,

our next EV Joure Fix will be held on June, 03rd 2025, in the S/W-Room of the Institute of Functional and Clinical Anatomy, Universitätsstraße 19.

The speaker will be Prof. Jochen Mattner, Clinical Microbilology, with the topic: "Role of OMVs in immune modulation and microbial...

Tech Talk | Biomarker Solutions & Precision Medicine Join us at TRC Erlangen to explore how biomarkers are transforming basic and clinical research.

Learn how advanced tools like Digital PCR & Olink's Proximity Extension Assay (PET TM ) Technology are supporting disease-focused investiga...

Cytiva User Day with focus on Extracellular Vesicles (EVs) on July 8th at the Palmeria/Uniklinik Erlangen:

Chromatography and filtration techniques are essential tools in EV research and production. Experts from Cytiva will present the latest advances in protein and EV purification techniques, cr...

_____________________________________________________________________________________________